Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro tests to evaluate immunotoxicity: a preliminary study.

M Carfi'1, A Gennari, I Malerba

  • 1ECVAM, IHCP, JRC, 21020 Ispra (VA), Italy. maria.carfi@jrc.it

Toxicology
|November 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up<sup>†</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Integration of translational research in phase III trials: A systematic review of breast cancer studies in a 5-year period.

Breast (Edinburgh, Scotland)·2025
Same author

On the dose-response association of fine and ultrafine particles in an urban atmosphere: toxicological outcomes on bronchial cells at realistic doses of exposure at the Air Liquid Interface.

Chemosphere·2024
Same journal

From inflammation to cytotoxicity: exposure pattern-dependent responses to alumina nanoparticles and dissolved hydrochloric acid in a human alveolar-capillary barrier model at the air-liquid interface.

Toxicology·2026
Same journal

Evaluation of 2,2'-Dimorpholinodiethyl Ether (DMDEE) in Pathology, Perinatal, and Genotoxicity Studies.

Toxicology·2026
Same journal

Retraction notice to "Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro" [Toxicology 283 (2011) 129-139].

Toxicology·2026
Same journal

Crystalline silica particles exposure modulated miRNA expression profiles in human macrophage-like THP-1 cells.

Toxicology·2026
Same journal

Sex-specific cellular and molecular mechanisms of PFAS-induced reproductive toxicity.

Toxicology·2026
Same journal

Neurotoxicity and mechanisms of deltamethrin and its metabolite 3-PBA in HT22 cells.

Toxicology·2026
See all related articles

This study evaluated in vitro assays for detecting chemical immunosuppression, finding that tests like mitogen responsiveness showed similar results across human and animal cells. These assays are crucial for chemical safety assessment under REACH regulations.

Area of Science:

  • Toxicology
  • Immunotoxicology
  • In vitro toxicology

Background:

  • The Registration, Evaluation and Authorisation of new and existing Chemicals (REACH) regulation necessitates alternative methods to animal testing.
  • The immune system is a key target for chemical toxicity, impacting human health.
  • Validated in vitro assays are needed to assess chemical-induced immunosuppression.

Purpose of the Study:

  • To evaluate the predictive capacity of a suite of in vitro assays for detecting chemical immunosuppression.
  • To compare the performance of these assays across human, rat, and murine cells.
  • To assess the utility of these methods for chemical safety evaluations under REACH.

Main Methods:

  • Utilized human, rat, and murine cell lines for in vitro testing.

Related Experiment Videos

  • Assessed endpoints including cytotoxicity, cytokine release, myelotoxicity, and mitogen responsiveness.
  • Calculated IC50 values for six selected chemical substances with known in vivo responses.

    • Main Results:

    • All tested in vitro assays successfully identified strong immunotoxic effects of tributyltin chloride (TBTC) and confirmed negative controls.
    • IC50 values varied between endpoints and species for some chemicals, but overall compound classification was consistent across assays.
    • The clonogenic test (CFU-GM) and mitogen responsiveness showed comparable IC50s between human and rodent cells, with exceptions for Cyclosporin A and TBTC.

    Conclusions:

    • The evaluated in vitro assays demonstrate predictive potential for identifying chemical immunosuppression.
    • These methods offer a viable alternative to animal testing for REACH compliance.
    • Further validation is warranted, but these assays show promise for routine chemical safety assessment.